CN Stock MarketDetailed Quotes

600436 Zhangzhou Pientzehuang Pharmaceutical

Watchlist
  • 230.40
  • -7.07-2.98%
Market Closed Oct 15 15:00 CST
139.00BMarket Cap46.68P/E (TTM)

Zhangzhou Pientzehuang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhangzhou Pientzehuang Pharmaceutical Q3 2024 Estimates Date

Currency：CNYOct 19, 2024

Estimate YoY
Revenue
2.72B
+6.49%
EPS
1.45
+0.69%
Analyst Rating
Strong Buy

Oct 15, 2024

Zhangzhou Pientzehuang Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.511B--
Oct 19, 20242024/Q3-- / 2.720B--
Aug 17, 20242024/Q22.480B / 3.116B--
Apr 20, 20242024/Q13.171B / 3.072B--
--2023/Q42.459B / 2.432B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.511B--
Oct 19, 20242024/Q3-- / 2.720B--
Aug 17, 20242024/Q22.480B / 3.116B--
Apr 20, 20242024/Q13.171B / 3.072B--
--2023/Q42.459B / 2.432B--

Unlock Free Earnings Estimates

Zhangzhou Pientzehuang Pharmaceutical Earnings Reports

  • Summary of Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.'s 2024 interim report.

    Aug 16 12:00 ET

  • Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.'s 2024 semi-annual report.

    Aug 16 12:00 ET

  • Announcement from Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. on semi-annual performance report for 2024.

    Jul 24 12:00 ET

  • Summary of the 2023 Annual Report of Zhangzhou Pianziying Pharmaceutical Co., Ltd.

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 15, 2024

    Strong Buy

    • Strong Buy

      62.50%

    • Buy

      37.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data